Regeneron Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (78)

Latest Posts

About This Stock More About This Stock
New Tensions Between The US And China Provoked Investors To Return To Safe-Haven Assets
Article By: JustForex
Wednesday, August 3, 2022 10:00 AM EDT
Geopolitical tensions rose higher during the day after Chinese battery giant CATL said it would suspend plans to invest billions of dollars in a new battery plant in the United States because of House Speaker Nancy Pelosi's trip to Taiwan.
In this article: CAT, MET, NTDOY, REGN, EBAY, MRNA, BKNG, UBER, PINS
Read
Small Cap Biotech Stocks Are Trending Well
Article By: Rod Raynovich
Monday, July 18, 2022 4:14 AM EDT
Despite a little weakness last week, small cap biotechs are trending well for traders. For investors entering the trade on July 5 all of our. focus stocks are up except ChemoCentryx.
In this article: REGN, PACB, EXAS, XBI, MRNA, TDOC, CRSP, ARKG, VCYT
Read
Best Biotech Stocks To Buy In 2022
Article By: Elliottwave Forecast
Tuesday, March 15, 2022 6:42 AM EDT
Biotechnology is the study of living creatures, biological systems, or derivatives to develop or improve healthcare products and therapies. This technology is connected with medical and pharmaceuticals, genomics, and food and chemical manufacturing.
In this article: BMY, JNJ, PFE, NVAX, REGN, AMGN, VRTX, AXSM, GMAB, RLAY
Read
Earnings Review: F5 Inc., Regeneron Inc.
Article By: Ingrid Hendershot
Monday, March 14, 2022 5:13 AM EDT
F5 reported fiscal first quarter revenues increased 10% to $687 million with net income and EPS increasing 7%. Regeneron reported fourth quarter sales more than doubled to $5 billion with net income and EPS each up.
In this article: FFIV, REGN Also: CNI, FDS, GD, GPC, HRL, JNJ, MA, MMM, MMS, NKE, PEP, SYK, TJX, UNH, UPS, CSCO, CTSH, FAST, GNTX, INTC, MSFT, PAYX, ROST, SBUX, SEIC, TROW, TSCO, BF-B, RTX
Read
3 Cathie Wood Stocks To Buy On The Dip
Article By: StockNews
Saturday, December 25, 2021 5:00 PM EDT
Institutional investor Cathie Wood gained popularity after her ETFs generated big gains last year. Wood asserted recently that her stocks are poised for long-term gains. Hence, we think investing in Wood’s portfolio stocks might be profitable.
In this article: REGN, TRMB, VRTX Also: SNY, SPY, ARKK
Read

Latest Tweets for $REGN

No tweets yet!

PARTNER HEADLINES

$REGN

Regeneron Pharmaceuticals’ Dupixent Has Multi-Billion-Dollar Potential: Polen Capital
David J. Tanner 1/31/2018 3:55:05 AM

Note it has only been approved in Japan. And only for those whom existing treatments are ineffective. So that's a MUCH smaller market. How small I don't know. But not enough to make me bite. $REGN

1 to 1 of 1 comments